Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Tilman Laeppchen
Introduction
Tilman Laeppchen is a notable inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of biomolecular research, particularly in the development of methods for clearing biomolecules from circulation. His innovative approach has the potential to enhance various medical applications.
Latest Patents
Tilman Laeppchen holds a patent titled "Agents for clearing biomolecules from circulation." This patent describes a method and a combination of agents that allow for the rapid clearance of an administered agent from circulation. The method involves using an Administration Agent with a reactive group and a Clearing Agent with another reactive group, which together form a bio-orthogonally reactive pair. The preferred reactive pair includes a cyclooctene or cyclooctyn as one reactant and a diene as the other. This innovative method can be utilized for the removal of any bindable molecule from circulation, including excess pre-targeting probes and imaging agents.
Career Highlights
Tilman Laeppchen is associated with Koninklijke Philips Corporation N.V., where he applies his expertise in biomolecular research. His work at Philips has allowed him to contribute to advancements in medical technology and improve patient outcomes through innovative solutions.
Collaborations
Tilman has collaborated with several talented individuals in his field, including Raffaella Rossin and Sandra Martina Van Den Bosch. These collaborations have fostered a creative environment that encourages the development of groundbreaking ideas and technologies.
Conclusion
Tilman Laeppchen's contributions to the field of biomolecular research exemplify the impact of innovative thinking in medicine. His patent for clearing biomolecules from circulation showcases his commitment to advancing healthcare solutions. Through his work at Koninklijke Philips Corporation N.V. and collaborations with fellow researchers, he continues to push the boundaries of what is possible in medical technology.